• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

TUG1基因敲低通过抑制耐阿霉素急性髓系白血病HL60/ADR细胞的糖酵解来增强阿霉素的细胞毒性。

TUG1 knockdown enhances adriamycin cytotoxicity by inhibiting glycolysis in adriamycin-resistant acute myeloid leukemia HL60/ADR cells.

作者信息

Chen Li, Zhao Hongmian, Wang Chao, Hu Ning

机构信息

Department of Hematology, Huaihe Hospital of Henan University No. 115 Ximen Street Kaifeng 475000 Henan China

出版信息

RSC Adv. 2019 Apr 8;9(19):10897-10904. doi: 10.1039/c9ra00306a. eCollection 2019 Apr 3.

DOI:10.1039/c9ra00306a
PMID:35515331
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9062713/
Abstract

Taurine-upregulated gene 1 (TUG1) has been reported as an oncogenic long non-coding RNA (lncRNA) in acute myeloid leukemia (AML). Nevertheless, the roles and molecular mechanism of TUG1 in drug resistance of AML cells are still unclear. Glycolysis level was evaluated by detecting glucose consumption and lactate production. qRT-PCR and Western blot were performed to detect TUG1, hexokinase2 (HK2) and pyruvate kinase isoenzyme M2 (PKM2) expressions. Adriamycin (ADR) cytotoxicity and apoptosis were assessed by MTT assay and flow cytometry, respectively. The changes of the protein kinase B (Akt) pathway were determined by Western blot analysis of phosphorylated-Akt (p-Akt) (ser473) and Akt. Our results showed that glycolysis was increased in HL60/ADR cells, as evidenced by the elevated glucose consumption and lactate production, as well as the increased HK2 and PKM2 expressions at mRNA and protein levels. TUG1 was up-regulated in HL60/ADR cells and TUG knockdown inhibited glycolysis. TUG1 knockdown enhanced ADR-induced cytotoxicity and apoptosis in HL60/ADR cells. TUG1 knockdown inhibited the Akt pathway and activation of the Akt pathway by 740Y-P attenuated the effects of TUG1 knockdown on ADR-induced cytotoxicity and apoptosis, as well as glycolysis in HL60/ADR cells. Taken together, TUG1 knockdown enhances adriamycin cytotoxicity in HL60/ADR cells inhibiting the glycolysis by inactivating the Akt pathway.

摘要

牛磺酸上调基因1(TUG1)已被报道为急性髓系白血病(AML)中的一种致癌长链非编码RNA(lncRNA)。然而,TUG1在AML细胞耐药中的作用和分子机制仍不清楚。通过检测葡萄糖消耗和乳酸生成来评估糖酵解水平。采用qRT-PCR和蛋白质免疫印迹法检测TUG1、己糖激酶2(HK2)和丙酮酸激酶同工酶M2(PKM2)的表达。分别通过MTT法和流式细胞术评估阿霉素(ADR)的细胞毒性和细胞凋亡。通过对磷酸化Akt(p-Akt)(ser473)和Akt进行蛋白质免疫印迹分析来确定蛋白激酶B(Akt)信号通路的变化。我们的结果表明,HL60/ADR细胞中的糖酵解增加,这通过葡萄糖消耗和乳酸生成的增加以及HK2和PKM2在mRNA和蛋白质水平的表达增加得到证明。TUG1在HL60/ADR细胞中上调,敲低TUG可抑制糖酵解。敲低TUG1可增强ADR诱导的HL60/ADR细胞的细胞毒性和细胞凋亡。敲低TUG1可抑制Akt信号通路,而740Y-P激活Akt信号通路可减弱敲低TUG1对ADR诱导的细胞毒性、细胞凋亡以及HL60/ADR细胞糖酵解的影响。综上所述,敲低TUG1可增强阿霉素对HL60/ADR细胞的细胞毒性,通过使Akt信号通路失活来抑制糖酵解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b82/9062713/808b699fced7/c9ra00306a-f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b82/9062713/9b260879586b/c9ra00306a-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b82/9062713/ac6e21a0bcda/c9ra00306a-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b82/9062713/37d64227883a/c9ra00306a-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b82/9062713/38571bf26e72/c9ra00306a-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b82/9062713/927659e1f44c/c9ra00306a-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b82/9062713/2287356dfb18/c9ra00306a-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b82/9062713/da1eb70ca1e4/c9ra00306a-f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b82/9062713/808b699fced7/c9ra00306a-f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b82/9062713/9b260879586b/c9ra00306a-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b82/9062713/ac6e21a0bcda/c9ra00306a-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b82/9062713/37d64227883a/c9ra00306a-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b82/9062713/38571bf26e72/c9ra00306a-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b82/9062713/927659e1f44c/c9ra00306a-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b82/9062713/2287356dfb18/c9ra00306a-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b82/9062713/da1eb70ca1e4/c9ra00306a-f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b82/9062713/808b699fced7/c9ra00306a-f8.jpg

相似文献

1
TUG1 knockdown enhances adriamycin cytotoxicity by inhibiting glycolysis in adriamycin-resistant acute myeloid leukemia HL60/ADR cells.TUG1基因敲低通过抑制耐阿霉素急性髓系白血病HL60/ADR细胞的糖酵解来增强阿霉素的细胞毒性。
RSC Adv. 2019 Apr 8;9(19):10897-10904. doi: 10.1039/c9ra00306a. eCollection 2019 Apr 3.
2
Knockdown of LncRNA-UCA1 suppresses chemoresistance of pediatric AML by inhibiting glycolysis through the microRNA-125a/hexokinase 2 pathway.敲低长链非编码 RNA-UCA1 通过 microRNA-125a/己糖激酶 2 通路抑制糖酵解从而抑制小儿急性髓系白血病的化疗耐药性。
J Cell Biochem. 2018 Jul;119(7):6296-6308. doi: 10.1002/jcb.26899. Epub 2018 Apr 16.
3
TUG1 confers Adriamycin resistance in acute myeloid leukemia by epigenetically suppressing miR-34a expression via EZH2.TUG1 通过 EZH2 表观遗传抑制 miR-34a 表达从而赋予急性髓系白血病阿霉素耐药性。
Biomed Pharmacother. 2019 Jan;109:1793-1801. doi: 10.1016/j.biopha.2018.11.003. Epub 2018 Nov 26.
4
Effect of pyruvate kinase M2-regulating aerobic glycolysis on chemotherapy resistance of estrogen receptor-positive breast cancer.丙酮酸激酶M2调节有氧糖酵解对雌激素受体阳性乳腺癌化疗耐药性的影响
Anticancer Drugs. 2018 Aug;29(7):616-627. doi: 10.1097/CAD.0000000000000624.
5
HOTAIRM1 knockdown enhances cytarabine-induced cytotoxicity by suppression of glycolysis through the Wnt/β-catenin/PFKP pathway in acute myeloid leukemia cells.HOTAIRM1 敲低通过 Wnt/β-catenin/磷酸果糖激酶 P 途径抑制糖酵解增强阿糖胞苷诱导的急性髓系白血病细胞的细胞毒性。
Arch Biochem Biophys. 2020 Feb 15;680:108244. doi: 10.1016/j.abb.2019.108244. Epub 2020 Jan 2.
6
Artesunate enhances adriamycin cytotoxicity by inhibiting glycolysis in adriamycin-resistant chronic myeloid leukemia K562/ADR cells.青蒿琥酯通过抑制耐阿霉素慢性髓性白血病K562/ADR细胞的糖酵解来增强阿霉素的细胞毒性。
RSC Adv. 2019 Jan 9;9(2):1004-1014. doi: 10.1039/c8ra08041k. eCollection 2019 Jan 2.
7
Long Non-Coding RNA Taurine Upregulated Gene 1 Targets miR-185 to Regulate Cell Proliferation and Glycolysis in Acute Myeloid Leukemia Cells in vitro.长链非编码RNA牛磺酸上调基因1靶向miR-185在体外调节急性髓系白血病细胞的增殖和糖酵解
Onco Targets Ther. 2020 Aug 7;13:7887-7896. doi: 10.2147/OTT.S238189. eCollection 2020.
8
TUG1 weakens the sensitivity of acute myeloid leukemia cells to cytarabine by regulating miR-655-3p/CCND1 axis.TUG1 通过调控 miR-655-3p/CCND1 轴降低急性髓系白血病细胞对阿糖胞苷的敏感性。
Eur Rev Med Pharmacol Sci. 2020 May;24(9):4940-4953. doi: 10.26355/eurrev_202005_21185.
9
Transcriptome-Wide Analysis of RNA N-Methyladenosine Modification in Adriamycin-Resistant Acute Myeloid Leukemia Cells.阿霉素耐药急性髓系白血病细胞中RNA N-甲基腺苷修饰的全转录组分析
Front Genet. 2022 Apr 28;13:833694. doi: 10.3389/fgene.2022.833694. eCollection 2022.
10
ALC1 knockdown enhances cisplatin cytotoxicity of esophageal squamous cell carcinoma cells by inhibition of glycolysis through PI3K/Akt pathway.ALC1 敲低通过 PI3K/Akt 通路抑制糖酵解增强食管鳞癌细胞对顺铂的细胞毒性。
Life Sci. 2019 Sep 1;232:116679. doi: 10.1016/j.lfs.2019.116679. Epub 2019 Jul 21.

引用本文的文献

1
Functions, mechanisms, and therapeutic implications of noncoding RNA in acute myeloid leukemia.非编码RNA在急性髓系白血病中的功能、机制及治疗意义
Fundam Res. 2023 May 16;5(4):1781-1794. doi: 10.1016/j.fmre.2023.04.012. eCollection 2025 Jul.
2
Warburg effect and lactylation in cancer: mechanisms for chemoresistance.癌症中的瓦伯格效应与乳酸化:化疗耐药机制
Mol Med. 2025 Apr 22;31(1):146. doi: 10.1186/s10020-025-01205-6.
3
Long noncoding RNAs in acute myeloid leukemia: biomarkers, prognostic indicators, and treatment potential.

本文引用的文献

1
Long non-coding RNA TUG1 sponges miR-197 to enhance cisplatin sensitivity in triple negative breast cancer.长链非编码 RNA TUG1 通过海绵吸附 miR-197 增强三阴性乳腺癌对顺铂的敏感性。
Biomed Pharmacother. 2018 Nov;107:338-346. doi: 10.1016/j.biopha.2018.07.076. Epub 2018 Aug 8.
2
LncRNA TUG1 promotes cell proliferation and suppresses apoptosis in osteosarcoma by regulating miR-212-3p/FOXA1 axis.长链非编码 RNA TUG1 通过调控 miR-212-3p/FOXA1 轴促进骨肉瘤细胞增殖并抑制凋亡。
Biomed Pharmacother. 2018 Jan;97:1645-1653. doi: 10.1016/j.biopha.2017.12.004. Epub 2017 Dec 8.
3
Long non-coding RNA taurine-upregulated gene 1 predicts unfavorable prognosis, promotes cells proliferation, and inhibits cells apoptosis in epithelial ovarian cancer.
急性髓系白血病中的长链非编码RNA:生物标志物、预后指标及治疗潜力
Cancer Cell Int. 2025 Apr 5;25(1):131. doi: 10.1186/s12935-025-03763-5.
4
modulates m6A modification to enhance acute myeloid leukemia resistance to adriamycin.调节m6A修饰以增强急性髓系白血病对阿霉素的耐药性。
Biomol Biomed. 2025 Apr 3;25(5):1038-1051. doi: 10.17305/bb.2024.11076.
5
Glycolysis and chemoresistance in acute myeloid leukemia.急性髓系白血病中的糖酵解与化疗耐药性
Heliyon. 2024 Aug 2;10(15):e35721. doi: 10.1016/j.heliyon.2024.e35721. eCollection 2024 Aug 15.
6
Unraveling the role of long non-coding RNAs in therapeutic resistance in acute myeloid leukemia: New prospects & challenges.解析长链非编码RNA在急性髓系白血病治疗耐药中的作用:新前景与挑战
Noncoding RNA Res. 2024 May 20;9(4):1203-1221. doi: 10.1016/j.ncrna.2024.05.009. eCollection 2024 Dec.
7
LncRNA TUG1 mediates microglial inflammatory activation by regulating glucose metabolic reprogramming.长链非编码 RNA TUG1 通过调节葡萄糖代谢重编程介导小胶质细胞炎症激活。
Sci Rep. 2024 May 27;14(1):12143. doi: 10.1038/s41598-024-62966-4.
8
Research Progress of Long Non-Coding RNA in Tumor Drug Resistance: A New Paradigm.长链非编码 RNA 在肿瘤耐药中的研究进展:一种新范式。
Drug Des Devel Ther. 2024 Apr 26;18:1385-1398. doi: 10.2147/DDDT.S448707. eCollection 2024.
9
LRRC1 knockdown downregulates MACF1 to inhibit the malignant progression of acute myeloid leukemia by inactivating β-catenin/c-Myc signaling.LRRC1 敲低通过失活 β-catenin/c-Myc 信号抑制 MACF1 下调来抑制急性髓系白血病的恶性进展。
J Mol Histol. 2024 Feb;55(1):37-50. doi: 10.1007/s10735-023-10170-5. Epub 2024 Jan 2.
10
Non-coding RNAs in leukemia drug resistance: new perspectives on molecular mechanisms and signaling pathways.非编码 RNA 在白血病耐药中的作用:分子机制和信号通路的新视角。
Ann Hematol. 2024 May;103(5):1455-1482. doi: 10.1007/s00277-023-05383-3. Epub 2023 Aug 1.
长链非编码RNA牛磺酸上调基因1预测上皮性卵巢癌预后不良,促进细胞增殖并抑制细胞凋亡。
Medicine (Baltimore). 2018 May;97(19):e0575. doi: 10.1097/MD.0000000000010575.
4
Knockdown of LncRNA-UCA1 suppresses chemoresistance of pediatric AML by inhibiting glycolysis through the microRNA-125a/hexokinase 2 pathway.敲低长链非编码 RNA-UCA1 通过 microRNA-125a/己糖激酶 2 通路抑制糖酵解从而抑制小儿急性髓系白血病的化疗耐药性。
J Cell Biochem. 2018 Jul;119(7):6296-6308. doi: 10.1002/jcb.26899. Epub 2018 Apr 16.
5
Long non-coding RNA taurine-upregulated gene 1 correlates with poor prognosis, induces cell proliferation, and represses cell apoptosis via targeting aurora kinase A in adult acute myeloid leukemia.长链非编码 RNA 牛磺酸上调基因 1 通过靶向成人急性髓系白血病中的极光激酶 A 与不良预后相关,诱导细胞增殖并抑制细胞凋亡。
Ann Hematol. 2018 Aug;97(8):1375-1389. doi: 10.1007/s00277-018-3315-8. Epub 2018 Apr 13.
6
Influence of microRNAs and Long Non-Coding RNAs in Cancer Chemoresistance.微小RNA和长链非编码RNA在癌症化疗耐药性中的作用
Genes (Basel). 2017 Mar 3;8(3):95. doi: 10.3390/genes8030095.
7
Long non-coding RNA TUG1 is involved in cell growth and chemoresistance of small cell lung cancer by regulating LIMK2b via EZH2.长链非编码RNA TUG1通过EZH2调控LIMK2b参与小细胞肺癌的细胞生长和化疗耐药。
Mol Cancer. 2017 Jan 9;16(1):5. doi: 10.1186/s12943-016-0575-6.
8
Resistance to chemotherapy is associated with altered glucose metabolism in acute myeloid leukemia.急性髓系白血病中对化疗的耐药与葡萄糖代谢改变有关。
Oncol Lett. 2016 Jul;12(1):334-342. doi: 10.3892/ol.2016.4600. Epub 2016 May 17.
9
Effectivity of a strategy in elderly AML patients to reach allogeneic stem cell transplantation using intensive chemotherapy: Long-term survival is dependent on complete remission after first induction therapy.采用强化化疗使老年急性髓系白血病患者接受异基因干细胞移植的策略有效性:长期生存取决于首次诱导治疗后的完全缓解。
Leuk Res. 2016 Jul;46:45-50. doi: 10.1016/j.leukres.2016.03.010. Epub 2016 Apr 9.
10
Targeting the mTOR Pathway in Leukemia.靶向白血病中的mTOR信号通路。
J Cell Biochem. 2016 Aug;117(8):1745-52. doi: 10.1002/jcb.25559. Epub 2016 Apr 6.